Stock fact sheet · data as of

GE HealthCare Technologies Inc. (GEHC): fair value, margin of safety and Wheel Score

Healthcare · Medical - Devices · United States · Blend

Close70.35
GLS fair value51.879 of 9 models
Margin of safety-36%price above fair value
Wheel Score58Fairout of 100
Health5/9Piotroski F-score
Moat4.9/10GLS 10-year score
Market cap$31.8B3.7M shares a day
Implied vol.40%near-the-money, 20-60 d
P/E20.0EPS 3.51
Dividend yield0.20%payout 4%
Beta0.85about the market
Next earnings28 Oct 2026in 12 days (before the open)

Is GEHC undervalued?

GEHC closed at 70.35 on 16 Oct 2026, more than 30% above the GLS average fair value of 51.87. Only 2 of the 9 models that produced a value sit above the price. By our models the shares are priced well beyond what the filed earnings, cash flow and book value support; the Sunday Scan drops names like this at the "below fair value" rule.

There is a wide gap between DDM (2.06) and DCF (133.02). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files GEHC under Blend.

Nine valuation models for GEHC

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF133.02+89%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number43.77-38%The most a defensive investor pays for the earnings and book value per share
Graham Growth100.30+43%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch36.35-48%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth8.98-87%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap66.06-6%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time37.22-47%Eight years of compounded free cash flow: the price at which the business pays for itself
DDM2.06-97%Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend
EPV39.05-44%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)-34.55-149%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target79.64+13%Analysts' average 12-month price target. Not in the average

Quality and financial health

GE HealthCare Technologies Inc. scores 5 of 9 on the Piotroski F-score: a middling result that falls one point short of the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. A GLS Moat score of 4.9/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.

Returns on capital are moderate - ROIC 10.2%, ROE 20.1%, ROA 5.6% - with debt at 0.96 times equity and a free-cash-flow yield of 2.8%.

The dividend yield is 0.20% with a payout ratio of 4% - a small yield that leaves most of the earnings in the business. Revenue comes mainly from AIS 71%, PDx 16%, PCS 13% (quarter Q2 FY2026).

Institutional ownership scores 10/10, insider activity 10/10 and Congressional trading 10/10 on the GLS smart-money scales; the last recorded Congressional buy was on 30 Jul 2026.

Piotroski F-score5 / 9ROIC10.2%
GLS Moat4.9 / 10ROE20.1%
Debt / equity0.96ROA5.6%
Free-cash-flow yield2.8%Payout ratio4%
Institutions10 / 10Insiders · Congress10 · 10 / 10

Wheel Score 58: Fair

A Wheel Score of 58 puts GE HealthCare Technologies Inc. in the Fair band - below the 70 the Sunday Scan requires. Value 0/25, Health 11/20, Moat 7/15, Premium 20/20 and Stability 20/20; the weakest part is Value (0/25).

Implied volatility is 40% on the near-the-money contracts 20-60 days out - inside the 35-60% range the Wheel Score pays full marks for: enough premium to be worth selling, not so much that the risk is unpaid. The option chain is deep: 65,357 contracts of open interest across all expiries, which means tight fills at most strikes.

Volume runs at 3.7M shares a day on a market cap of $31.8B, with a beta of 0.85; the Stability part of the Wheel Score gives that 20 of 20.

PartPointsFrom
Value0 / 25-36% margin of safety
Health11 / 20Piotroski 5/9
Moat7 / 15moat 4.9/10
Premium20 / 20implied volatility 40%
Stability20 / 203.7M shares/day, $31.8B cap, beta 0.85

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

GE HealthCare Technologies Inc. reports earnings on 28 Oct 2026 (before the open) - inside the 14-day window the Sunday Scan avoids, because a put sold now would carry the report's gap risk. The shares go ex-dividend on 23 Oct 2026 (0.0400 per share), so a covered call sold before then carries a small early-assignment risk around that date.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Medical - Devices

The 12 companies below are the closest to GE HealthCare Technologies Inc. by market cap within the Medical - Devices industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
DXCM
DexCom, Inc.
87.7180.03-10%78Good$33.1B
PHG
Koninklijke Philips N.V.
25.0037.85+34%82Prime$24.2B
EW
Edwards Lifesciences Corporation
88.1039.75-122%62Fair$50.8B
ZBH
Zimmer Biomet Holdings, Inc.
91.77134.51+32%87Prime$17.5B
BSX
Boston Scientific Corporation
44.1465.77+33%95Prime$64.0B
PEN
Penumbra, Inc.
320.12139.38-130%54Fair$12.6B
SNN
Smith & Nephew plc
27.8837.94+27%90Prime$11.7B
ALGN
Align Technology, Inc.
149.34125.50-19%66Good$10.6B
GMED
Globus Medical, Inc.
78.84112.94+30%92Prime$10.6B
BIO
Bio-Rad Laboratories, Inc.
364.82246.29-48%58Fair$9.8B
GKOS
Glaukos Corporation
165.60--45Weak$9.8B
SYK
Stryker Corporation
281.63211.44-33%68Good$108.0B

⚖ Compare GEHC with 7 of them   All Healthcare stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about GEHC

Is GEHC undervalued right now?

No: at 70.35 the stock trades 36% above the GLS average fair value of 51.87 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.

What is the Wheel Score of GEHC and what does it mean?

GEHC scores 58 out of 100 (Fair). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.

What is the GLS fair value for GEHC?

51.87 per share as of 16 Oct 2026 - the simple average of the 9 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does GE HealthCare Technologies Inc. report earnings next?

The next earnings report is due on 28 Oct 2026 (before the open), 12 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does GEHC have listed options, and how liquid are they?

Yes. The nightly snapshot found 950 listed contracts with 65,357 open interest across all expiries and implied volatility of 40% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.